工业水处理 ›› 2007, Vol. 27 ›› Issue (3): 75-77. doi: 10.11894/1005-829x.2000.20(4).75

• 经验交流 • 上一篇    下一篇

组合生物技术处理D-抗坏血酸钠工业废水

潘峰1, 时蕾1, 王学锋1, 任蓓蕾2, 崔凤霞2   

  1. 1. 河南师范大学化学与环境科学学院, 河南新乡 453007;
    2. 郑州拓洋实业有限公司, 河南郑州 450008
  • 收稿日期:2006-10-20 出版日期:2007-03-20 发布日期:2010-10-01
  • 作者简介:潘峰(1969- ), 2004 年毕业于中国科学院生态环境研究中心, 博士, 副教授。电话: 0373-3326335, E-mail:fengpan@henannu.edu.cn。

Treatment for D-sodium ascorbate indus trial was tewater by combined biotechnology

Pan Feng1, Shi Lei1, Wang Xuefeng1, Ren Beilei2, Cui Fengxia2   

  1. 1. College of Chemistry & Environmental Science, Henan Normal University, Xinxiang 453007, China;
    2. Zhengzhou Tuoyang Industrial Co., Ltd., Zhengzhou 450008, China
  • Received:2006-10-20 Online:2007-03-20 Published:2010-10-01

摘要:

对高浓度制药废水首先进行浓缩蒸发预处理,彻底除硫除盐以后,再通过一系列的厌氧、兼氧、缺氧-好氧组合处理,充分发挥在不同环境条件下各类微生物代谢降解有机污染物的功能,使废水中COD由2.8×104mg/L降到300mg/L以下,经过5个月的稳定运行后,于2005年1月12日顺利通过郑州市环保局组织的达标验收。

关键词: D-抗坏血酸钠, 水解酸化, 生物处理技术

Abstract:

Highly concentrated pharmaceutical wastewater has been pretreated by evaporation first to remove sulphur and inorganic salt thoroughly. Then a series of aerobic,anaerobic and anaerobic-aerobic treatment are carried out combinedly. The concentration of the COD of influent water changes from 2.8 ×104 mg/L to less than 300 mg/L because of the degradation of different microorganisms. After a 5 month stable running,the project was smoothly through the acceptance check fromZhengzhou Environmental Protection Bureau on January 12,2005.

Key words: D-sodium ascorbate, hydrolysis acidification, biological treatment technology

中图分类号: